鹿得医疗
(832278)
| 流通市值：7.46亿 | | | 总市值：17.39亿 |
| 流通股本：7554.80万 | | | 总股本：1.76亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 234,676,473.81 | 147,727,957.74 | 65,987,957.04 | 329,263,803.5 |
| 营业收入 | 234,676,473.81 | 147,727,957.74 | 65,987,957.04 | 329,263,803.5 |
| 二、营业总成本 | 215,769,586.72 | 135,217,588.06 | 62,060,081.82 | 298,448,745.22 |
| 营业成本 | 175,847,183.36 | 109,933,761.81 | 49,088,525.99 | 236,319,003.41 |
| 税金及附加 | 2,382,308.68 | 1,948,567.98 | 1,314,707.25 | 2,761,602.1 |
| 销售费用 | 14,764,929.98 | 9,627,731.61 | 4,436,471.62 | 23,558,801.03 |
| 管理费用 | 14,598,990.31 | 9,791,366.98 | 5,003,737.71 | 23,276,151.37 |
| 研发费用 | 10,440,204.85 | 6,758,350.41 | 3,170,601.68 | 14,371,588.8 |
| 财务费用 | -2,264,030.46 | -2,842,190.73 | -953,962.43 | -1,838,401.49 |
| 其中:利息费用 | 187,405 | 110,042.28 | 2,328.33 | 122,722.03 |
| 其中:利息收入 | 1,942,205.98 | 1,056,357.83 | 544,121.95 | 2,294,955.3 |
| 加:公允价值变动收益 | 505,855.59 | 464,139.8 | 313,967.27 | -1,021,859.42 |
| 加:投资收益 | 318,172.58 | 394,144.92 | 25,433.17 | 3,293,729.83 |
| 资产处置收益 | 13,008.82 | 13,008.82 | 13,358.33 | 62,617.43 |
| 资产减值损失(新) | 1,113,811.34 | 767,051.49 | 126,960.96 | 33,793.31 |
| 信用减值损失(新) | -997,450.62 | -1,553,125.22 | -643,990.01 | -775,217.41 |
| 其他收益 | 655,975.81 | 515,246.09 | 407,761.1 | 1,249,994.6 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 20,516,260.61 | 13,110,835.58 | 4,171,366.04 | 33,658,116.62 |
| 加:营业外收入 | 5,491.45 | 4,314.85 | 4,212.38 | 1,178,583.97 |
| 减:营业外支出 | 159,151.18 | 137,413.06 | 93,385.22 | 101,569.47 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 20,362,600.88 | 12,977,737.37 | 4,082,193.2 | 34,735,131.12 |
| 减:所得税费用 | 1,964,840.48 | 1,089,008.74 | 193,463.99 | 3,045,246.68 |
| 六、净利润 | 18,397,760.4 | 11,888,728.63 | 3,888,729.21 | 31,689,884.44 |
| 持续经营净利润 | 18,397,760.4 | 11,888,728.63 | 3,888,729.21 | 31,689,884.44 |
| 归属于母公司股东的净利润 | 18,397,981.89 | 11,888,728.63 | 3,888,729.21 | 31,689,884.44 |
| 少数股东损益 | -221.49 | - | - | - |
| (一)基本每股收益 | 0.11 | 0.07 | 0.02 | 0.18 |
| (二)稀释每股收益 | 0.11 | 0.07 | 0.02 | 0.18 |
| 九、综合收益总额 | 18,397,760.4 | 11,888,728.63 | 3,888,729.21 | 31,689,884.44 |
| 归属于母公司股东的综合收益总额 | 18,397,981.89 | 11,888,728.63 | 3,888,729.21 | 31,689,884.44 |
| 归属于少数股东的综合收益总额 | -221.49 | - | - | - |
| 公告日期 | 2024-10-29 | 2024-08-28 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |